You just read:

Lexicon Pharmaceuticals Announces Opt-In Decision For U.S. Co-Promotion Of Sotagliflozin With Sanofi In Type 1 Diabetes

News provided by

Lexicon Pharmaceuticals, Inc.

Jul 31, 2017, 18:01 ET